CAT# | CPM-1-0085 |
Sequence | IMDQVPFSV |
Size | 50 Test, 100 Test | Antigen | Cancer | Epitope Origin | gp100 (mutant) | MHC Restriction | HLA-A_02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0551 | H-2Kd Erk2 K136Q tetramer-QYIHSANVL-PE labeled | Inquiry | ||
CPM-1-0712 | HLA-A_11_01 EBV LMP2 KIL tetramer-KILLARLFLY-PE labeled | Inquiry | ||
CPM-1-0775 | HLA-A_02_01 NY ESO tetramer-LMWITQAFL-PE labeled | Inquiry | ||
CPM-1-0334 | H-2Db Survivin tetramer-ATFKNWPFL-BV421 labeled | Inquiry | ||
CPM-1-0770 | HLA-B_35_01 NP tetramer-LPFDRTTVM-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...
Caprooyl tetrapeptide-3, an anti-wrinkle peptide, a reaction product of caproic acid and tetrapeptide-3, compris ...
Teriparatide is a human parathyroid hormone analog with the same structure as the N-terminal 34 amino acid seque ...
Gap 19 is a nonapeptide derived from the cytoplasmic loop (CL) of Connexin-43 (Cx43). Cx43 is a predominant card ...
Background Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be acc ...